نتایج جستجو برای: gist tumor

تعداد نتایج: 430446  

Journal: :Molecular cancer therapeutics 2014
Mamoru Tanaka Hiromi Kataoka Shigenobu Yano Hiromi Ohi Kazuhiro Moriwaki Haruo Akashi Takahiro Taguchi Noriyuki Hayashi Shingo Hamano Yoshinori Mori Eiji Kubota Satoshi Tanida Takashi Joh

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. Except for surgical resection, no effective treatment strategies have been established. Photodynamic therapy (PDT) consists of intravenous administration of a photosensitizer, activated by a specific wavelength of light, which produces reactive oxygen species that directly kill tumor cel...

Journal: :Cancer discovery 2015
Leili Ran Inna Sirota Zhen Cao Devan Murphy Yuedan Chen Shipra Shukla Yuanyuan Xie Michael C Kaufmann Dong Gao Sinan Zhu Ferdinando Rossi John Wongvipat Takahiro Taguchi William D Tap Ingo K Mellinghoff Peter Besmer Cristina R Antonescu Yu Chen Ping Chi

UNLABELLED Gastrointestinal stromal tumor (GIST), originating from the interstitial cells of Cajal (ICC), is characterized by frequent activating mutations of the KIT receptor tyrosine kinase. Despite the clinical success of imatinib, which targets KIT, most patients with advanced GIST develop resistance and eventually die of the disease. The ETS family transcription factor ETV1 is a master reg...

Journal: :International Journal of Biomedical and Advance Research 2014

2012
Kai-Hsi Hsu

The term gastrointestinal stromal tumor (GIST) in the description of a specific group of gastrointestinal nonepithelial tumors lacking the microscopic evidence of smooth muscle or characteristics of neural immunoreactivity was first introduced by Mazur and Clark (Mazur & Clark, 1983). The common origin of GIST and interstitial cell of Cajal (ICC), the pacemaker cells in the digestive tract, was...

Journal: :Cancer Research 2021

Abstract Oncogenic KIT or PDGFRA receptor tyrosine kinase mutations are compelling therapeutic targets in gastrointestinal stromal tumor (GIST), and treatment with the KIT/PDGFRA inhibitor imatinib is standard of care for patients advanced GIST. Polyclonal emergence secondary main mechanism progression, making it challenging to overcome KIT/PDGFRA-inhibitor resistance. It unclear whether there ...

Journal: :The European Research Journal 2023

Duodenal gastrointestinal stromal tumor (GIST) is rarely observed in the system. It can be confused with pancreas pathologies as it shows an extramural growth pattern. The case here presented of a 65-year-old male who complaints abdominal pain, nausea and vomiting. On contrast tomography, centrally hypodense, necrotic mass, 140×115×100 mm size, was head. With preliminary diagnosis neuroendocrin...

2013
Kwang Baek Kim Gwang Ha Kim

Endoscopists usually make a diagnosis in the submucosal tumor depending on the subjective evaluation about general images obtained by endoscopic ultrasonography. In this paper, we propose a method to extract areas of gastrointestinal stromal tumor (GIST) and lipoma automatically from the ultrasonic image to assist those specialists. We also propose an algorithm to differentiate GIST from non-GI...

Journal: :Journal of Coloproctology 2017

Journal: :World Journal of Surgical Oncology 2007

2015
Hajar Hachim Anass Mohammed Majbar Mouna Alaoui Mohamed Raiss Farid Sabbah Abdelmalek Hrora Mohamed Ahallat

INTRODUCTION The gastrointestinal stromal tumors (GIST) are mesenchymal tumors, most commonly affecting the stomach and small bowel. Only few cases of port-site recurrence after laparoscopic treatment have been reported. We herein report the case of a parietal recurrence on the extraction incision site, 7 years after laparoscopic surgery for small bowel GIST. CASE REPORT A 47 years-old female...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید